NCT02969564View on ClinicalTrials.gov

18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

September 14, 2020

Conditions
Bone MetastasesProstate Cancer
Interventions
OTHER

scintigraphy 99mTc-MDP-SPECT/CT.

SPECT/CT will be performed for every patient in the frame of their clinical follow up

OTHER

18F-NaF-PET/MR

a 18F-NaF-PET/MR will be performed, in the frame of this clinical study, to the patients to assess the difference of sensitivity of the 2 exams

Trial Locations (1)

1205

Geneva University Hospital, Geneva

All Listed Sponsors
collaborator

University Hospital, Geneva

OTHER

lead

Valentina Garibotto

OTHER

NCT02969564 - 18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients. | Biotech Hunter | Biotech Hunter